Humana Inc. (HUM)
328.19 USD -18.23 (-5.26%) Volume: 2.62M
Humana Inc.’s stock price currently stands at 328.19 USD, experiencing a dip of 5.26% this trading session with a trading volume of 2.62M. The healthcare giant has seen a significant YTD decrease of 28.31%, indicating a turbulent year for HUM investors.
Latest developments on Humana Inc.
Today, Humana Inc‘s stock price experienced a significant drop to $346.42 as Essentia Health announced its decision to no longer accept Medicare Advantage insurance plans administered by UnitedHealthcare and Humana starting January 1. This move by Essentia Health to drop from Medicare Advantage networks at UnitedHealthcare and Humana has impacted the stock performance of Humana (NYSE:HUM). Additionally, CVS and Humana stocks dipped amidst new mental health guidelines, according to a Leerink note. Despite this, Davis Selected Advisers raised its stock position in Humana Inc, indicating ongoing interest in the health insurance giant’s performance compared to other healthcare stocks.
Humana Inc. on Smartkarma
Analysts at Baptista Research have recently provided insightful coverage on Humana Inc. According to their research reports, Humana has shown a mixed set of results for the first quarter of 2024, with adjusted expectations for the upcoming year. The company has reaffirmed its full-year adjusted EPS guidance and increased its membership growth outlook, showcasing operational resilience and strategic expansions. This performance is supported by positive medical cost trends and growth in their primary care business.
Furthermore, Baptista Research also highlighted the impacts on Pharmacy Benefit Managers (PBMs) resulting from IRA changes and other major drivers for Humana Inc. CEO Bruce Broussard and CFO Susan Diamond shared important insights into the company’s financial performance and future outlook. Broussard emphasized Humana’s strong start to 2024, reaffirming the full-year adjusted earnings per share (EPS) guidance and providing an increased individual MA membership growth outlook.
A look at Humana Inc. Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 3 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Humana Inc has received a moderate overall outlook based on the Smartkarma Smart Scores. With a score of 3 in Value, Dividend, Growth, Resilience, and Momentum, the company seems to have a stable and balanced performance across various factors. This suggests that Humana Inc is positioned well in terms of its financial health, dividend payouts, growth potential, ability to withstand economic challenges, and market momentum.
As a managed health care company serving members in the US and Puerto Rico, Humana Inc offers coordinated health care services through different plans to various customer groups. Despite the average scores across different factors, the company’s consistent performance in key areas indicates a steady outlook for its long-term prospects in the managed health care industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
